Rchr
J-GLOBAL ID：200901058861969084
Update date: Jan. 17, 2024
Katayama Hajime
カタヤマ ハジメ | Katayama Hajime
Research field (1)：
Pharmaceuticals - chemistry and drug development
Research keywords (3)：
合成化学
, 医学分子機能学
, Chemical synthesis
Research theme for competitive and other funds (6)：
抗癌剤の開発
アミノークライゼン転位反応
生物活性を有するヘテロ環化合物の合成
Exploration of Anti-cancer Agents
Amino-Claisen Rearrangement
Synthesis of Biologically Active Heterocyclic Comupounds
Show all
MISC (31)：
Synthesis of indolo[1,2-b]indazole berivatives. Heterocyiles. 2003. 61, 147
Inhibition of DNA topoisomerases II and/or by pyrazolo[1,5-a]indole berivatives and their growth inhibition activities. Molecular Pharmacology. 2002. 62, 873
Intramolecular aromatic amination by a hydrazing gronp for the Synthsis of indolo[1,2-b]indazole berivatives. Tetrahedrim hett. 2002. 43巻(19), 3577
Anti-cancer Activities of Pyrazolo[1, 5-a]indole Derivatives. Chem. Pharm. Bull. 2000. 48. 11. 1628-1633
Synthetic inhibitors of DNA topoisomerase (I)and(II). Chem. Pharm. Bull. 1999. 47. 1. 48-53
ｍore...
Patents (1)：
ピラゲロインドリウム誘導体
Works (4)：
抗癌剤の開発
1997 - 現在
Exploration of Anti-cancer Agents
1997 - 現在
DNAトポイソメラーゼ阻害剤の開発
2000 - 2003
Exploration of DNA topoisomerase Inhibitors
2000 - 2003
Education (2)：
- 1969 Kyoto University
- 1969 Kyoto University Graduate School, Division of Pharmaceutical Sciences
Professional career (1)：
(BLANK) (Kyoto University)
Association Membership(s) (5)：
イギリス化学会
, アメリカ化学会
, 有機合成化学協会
, 日本化学会
, 日本薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
